EULAR Edgar Stene Prize competition

Every year, the competition is co-ordinated by EULAR PARE. Competition details are distributed to the EULAR PARE member organisations so they can run the competition nationally. The Edgar Stene Prize is awarded at the Opening Plenary Session of the EULAR European Congress of Rheumatology to the person with an RMD submitting the best essay describing their individual experience of living with their condition around a specific topic.

Participate in the next competition through a EULAR PARE national member organisation! Call now open!

2023 EULAR Edgar Stene Prize topic:

“How better communication with my doctor improved my life with an RMD”

See the list of EULAR PARE Member Organisations

Who can apply

EULAR PARE Member Organisations invite people living with RMDs (minimum age of 18 years) in their respective countries to participate in the competition by writing and submitting an essay on the topic of the year. Essays may be written in any national language and should not exceed two typewritten pages.

Direct entries to EULAR will not be accepted.

Deadline for submissions by EULAR PARE member organisations: 20 January 2023

Competition rules

The 2023 EULAR Edgar Stene Prize competition rules are distributed to EULAR PARE Member Organisations so they can run the competition nationally.

Member organisations select the best entry from their country to submit to the EULAR Office for judging by the Edgar Stene Prize Jury.

The winners are selected by the 2023 Edgar Stene Prize Jury, to be announced on 15 March 2023. The first prize will be awarded at the Opening Plenary session taking place at the EULAR European Congress of Rheumatology, EULAR 2023, 31 May.

Prizes

The competition has a first prize money of EUR 1,000 including a travel bursary to attend the EULAR 2023 Opening Plenary session and an invitation to the EULAR Congress dinner in Milan*. Second and third prizes are awarded with prize money of EUR 700 and EUR 300 respectively.

See the 2023 EULAR Edgar Stene Prize competition rules for more details.

About the Edgar Stene Prize

First awarded in June 1975 during the EULAR European Congress of Rheumatology in Helsinki-Finland, the Edgar Stene Prize was created by EULAR to honour the memory of Edgar W Stene.

Stene Prize Booklets

Access the Stene Prize booklets from previous competition editions to read the inspiring and moving stories from its winners:

2022	How treating my RMD has influenced my hopes for the future
2021	How digital solutions benefit my life as a person with an RMD
2020	Being a person with a rheumatic or musculoskeletal disease – How my voluntary work benefits me
2019	My ideal employer - Work without barriers for people with rheumatic and musculoskeletal diseases
2018	My personal champion - Supporting my everyday life with a rheumatic and musculoskeletal disease
2017	Don’t Delay, Connect Today - Early diagnosis and access to care in rheumatic and musculoskeletal diseases – the ideal world and the reality
2016	Living with a rheumatic or musculoskeletal disease – How I take action to enjoy life to the full
2015	Taking control of my life: working together with health professionals to take control of my personal goals
2014	Vision 2043: My ideal world for people with rheumatic or musculoskeletal diseases
2013	Growing up or growing older - my secret for ageing with a rheumatic or musculoskeletal disease
2012	Overcoming the challenges of getting around with a rheumatic or musculoskeletal disease
2011	How exercise improves my life with a rheumatic disease
2010	Living with a rheumatic disease - my daily reality
2009	Rare but no less severe: the challenge of coping with a rare rheumatic disease

EULAR in the context of persons living with RMDs

EULAR exists to reduce the burden of RMDs on individuals and society, and to improve treatment, prevention and rehabilitation outcomes. It demonstrates the impact of RMDs on society, the economy and individuals – including families and loved ones.
The EULAR family gives its time to share experiences of living or working with a condition, and to raise awareness of the need for early diagnosis and the right treatment at the right time.